PACS Group, Inc. PACS
- Market cap
- $6.6B
- P/E
- 24.3×
Follow PACS
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | 12.54 | 7.50 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | — | — | — | — | — | 43.92 | 40.09 |
High Price
|
|||
| — | — | — | — | — | — | — | 32,433 | 45,680 | 47,455 |
Employees
|
|||
| — | — | — | — | — | 0 | 0 | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | — | — | 1,167 | 2,422 | 3,111 | 4,090 | 5,289 |
Revenue
|
|||
| — | — | — | — | — | 16.06% | 16.54% | 14.37% | 12.41% | 14.75% |
Gross Margin
|
|||
| — | — | — | — | — | 81 | 207 | 157 | 102 | 284 |
EBT
|
|||
| — | — | — | — | — | 6.98% | 8.55% | 5.06% | 2.48% | 5.38% |
EBT Margin
|
|||
| — | — | — | — | — | 48 | 150 | 113 | 55 | 191 |
Net Income
|
|||
| — | — | — | — | — | 8 | 24 | 32 | 44 | 59 |
Depreciation
|
|||
| — | — | — | — | — | 9.06 | 18.82 | 24.17 | 27.89 | 33.86 |
Revenue/Sh
|
|||
| — | — | — | — | — | 0.37 | 1.17 | 0.88 | 0.38 | 1.23 |
Earnings/Sh
|
|||
| — | — | — | — | — | 0.45 | 0.72 | 0.49 | 2.50 | 2.59 |
Cash Flow/Sh
|
|||
| — | — | — | — | — | (0.96) | (0.18) | (0.35) | (0.44) | (0.67) |
Capex/Sh
|
|||
| — | — | — | — | — | (0.52) | 0.54 | 0.15 | 2.06 | 1.92 |
Free CF/Sh
|
|||
| — | — | — | — | — | 0.00 | 0.53 | 0.79 | 4.88 | 6.10 |
Book Value/Sh
|
|||
| — | — | — | — | — | 129 | 129 | 129 | 147 | 156 |
Shares
|
|||
| — | — | — | — | — | 26.89 | 26.89 | 26.89 | 32.20 | 31.47 |
PE Ratio
|
|||
| — | — | — | — | — | 0.89 | 0.89 | 0.89 | 0.47 | 1.13 |
PS Ratio
|
|||
| — | — | — | — | — | 22.16 | 22.16 | 22.16 | 2.69 | 6.30 |
PB Ratio
|
|||
| — | — | — | — | — | 1.10 | 1.10 | 1.10 | 0.50 | 1.16 |
EV/Sales
|
|||
| — | — | — | — | — | (546.96) | (546.96) | (546.96) | 6.72 | 20.52 |
EV/FCF
|
|||
| — | — | — | — | — | 58 | 93 | 64 | 367 | 404 |
Op' Cash Flow
|
|||
| — | — | — | — | — | (124) | (23) | (45) | (65) | (105) |
Capex
|
|||
| — | — | — | — | — | (66) | 70 | 19 | 302 | 300 |
FCF
|
|||
| — | — | — | — | — | — | 27 | 265 | (40) | 68 |
Working Cap'
|
|||
| — | — | — | — | — | — | 500 | 733 | 266 | 349 |
Total Debt
|
|||
| — | — | — | — | — | — | 441 | 659 | 108 | 152 |
Net Debt
|
|||
| — | — | — | — | — | 0 | 69 | 102 | 716 | 952 |
Sh' Equity
|
|||
| — | — | — | — | — | 0.00% | 12.23% | 3.78% | 1.27% | 3.54% |
ROA
|
|||
| — | — | — | — | — | 0.00% | 28.10% | 17.07% | 9.34% | 17.52% |
ROIC
|
|||
| — | — | — | — | — | 0.00% | 0.00% | 132.50% | 13.64% | 22.96% |
ROE
|
|||
PACS Group, Inc. peers in Medical Care Facilities
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| CHE Chemed Corporation | $6.5B | 25.7× | Compare |
| LFST LifeStance Health Group, Inc. | $4.5B | 89.0× | Compare |
| CON Concentra Group Holdings Parent, Inc. | $4.4B | 22.6× | Compare |
| ENSG The Ensign Group, Inc. | $10.1B | 26.7× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| UHS Universal Health Services, Inc. | $10.5B | 7.2× | Compare |
| DVA DaVita Inc. | $11.2B | 14.3× | Compare |
| FMS Fresenius Medical Care AG & Co. KGaA | $11.9B | 11.8× | Compare |
| EHC Encompass Health Corporation | $12.0B | 19.9× | Compare |
PACS Group, Inc. (PACS) key facts
- PACS Group, Inc. (PACS) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
- PACS Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 29.3% from fiscal 2024.
- Net income was $191.5 million, or $1.23 per share (basic), a net margin of 3.62%.
- As of September 25, 2026, PACS traded at $41.30, a market capitalization of $6.6 billion.
- At that price the stock trades at 24.3× trailing-twelve-month earnings and 1.2× sales.
- Return on equity was 23.0% and debt-to-equity 0.22.
PACS Group, Inc. (PACS) Latest News
21 Sep
PACS Group, Inc. announced that Chief Legal Officer and Corporate Secretary John Mitchell has retired, effective Sept. 18, 2026, and will remain as a consultant through the transition. Patrick J. Murphy was named his successor as Chief Legal Officer and Corporate Secretary, with the appointment effective Sept. 21, 2026. Murphy brings more than 20 years of senior in-house and public-sector experience, including GE Healthcare, Fresenius Medical Care, King & Spalding, and roles in the FBI and the U.S. Senate Judiciary Committee. Chairman and CEO Jason Murray praised Mitchell’s leadership and noted Murphy’s appointment as a strategic move to support PACS as it grows. Mitchell said he looks forward to assisting Pat during the transition. The release describes PACS as a Salt Lake City–based post-acute healthcare platform with 355 facilities in 20 states and a PACS Services division providing technology and administrative support. It includes standard forward-looking statements disclaimers. Seasoned replacement with healthcare and public-sector background will shape governance and risk management, influencing PACS's future operations.
8 Sep
PACS Group acquires 32 facilities in Florida, expanding its operational footprint in the state. Acquisition of 32 facilities marks a major strategic expansion in Florida.
2 Sep
PACS Group shares rose 3.3% after the company announced Florida expansion plans and completed additional Eduro acquisitions. Florida expansion and Eduro acquisitions represent major strategic growth initiatives.
1 Sep
PACS Group acquires operations of 32 facilities across Florida and closes on additional previously announced Eduro facilities. Acquisition of 32 facilities marks major operational expansion that will materially boost scale and revenue trajectory.
19 Aug
PACS Group faces ongoing legal risks yet analysts maintain a buy rating on the stock due to underlying operational strengths and growth prospects. Legal risks create moderate pressure on PACS operations and sentiment without fundamentally shifting long-term trajectory.
15 Aug
PACS Group shares fell 8.3% after the company raised 2026 revenue guidance while keeping buybacks steady. Raised 2026 revenue guidance improves forward outlook while steady buybacks leave capital return policy unchanged.
11 Aug
PACS Group, Inc. released transcript of its Q2 2026 earnings call covering financial results and outlook. Earnings call transcript delivers key quarterly metrics and guidance directly affecting PACS stock trajectory.
8 Aug
PACS Group reported Q2 financial results and operational updates during its earnings call, covering revenue, earnings metrics and forward guidance for the company. Q2 earnings results and guidance directly shape investor views on financial trajectory and valuation.
5 Aug
PACS Group Inc posted strong revenue growth in Q2 2026 and raised its financial outlook. Strong revenue growth and raised guidance signal major positive shifts in financial performance and market trajectory for PACS.
PACS Group, Inc. released its Q2 2026 earnings call summary covering quarterly financial results and outlook. Q2 2026 earnings details and outlook directly shape investor views and stock valuation for PACS.
4 Aug
PACS Group, Inc. released its second quarter 2026 financial results. Quarterly earnings releases deliver core performance data that frequently drive major shifts in valuation and investor positioning.
PACS Group, Inc. exceeded Q2 earnings and revenue estimates. Quarterly earnings beat offers moderate short-term market boost without shifting long-term trajectory.
29 Jun
PACS Group acquires operations of 34 facilities across Texas, Montana, New Mexico, North Dakota, South Dakota, and Utah. Acquisition of 34 facilities represents major strategic expansion across multiple states.
18 May
PACS Group's operational results and business fundamentals outperform what its reported earnings figures alone indicate, pointing to stronger underlying growth and efficiency. Favorable view of PACS results beyond earnings can lift near-term investor sentiment and valuation without shifting long-term company trajectory.
14 May
PACS Group released Q1 earnings call highlights covering financial results, operational updates, and forward guidance. Q1 earnings highlights detail financial performance and strategic outlook significantly influencing PACS Group's trajectory and investor sentiment.
PACS Group stock surged 22.1% after beating Q1 earnings expectations, raising full-year guidance, and launching a share buyback program. Q1 earnings beat, guidance increase, and buyback initiation demonstrate strong financial momentum and enhance shareholder value.
13 May
PACS Group (PACS) beat Q1 earnings expectations and announced a US$250 million share buyback, leading to a reassessment of its valuation amid positive market reaction. Q1 earnings beat combined with $250 million buyback demonstrates strong financial position and management confidence, poised to significantly lift stock valuation and investor sentiment.
12 May
PACS Group, Inc. (PACS) stock surged today on positive catalysts boosting investor sentiment. Stock surge reflects major positive developments likely to significantly enhance future performance and market trajectory.
PACS Group, Inc. released Q1 2026 earnings call summary detailing financial results, operational updates, and forward guidance. Q1 2026 earnings highlights directly affect financial performance metrics and investor outlook for PACS.
PACS Group Inc (PACS) Q1 2026 earnings call highlighted strong revenue growth despite ongoing challenges. Strong revenue growth bolsters financial performance but challenges limit broader trajectory shifts.
11 May
PACS Group, Inc. (PACS) Q1 earnings and revenues exceeded analyst estimates. Beating Q1 earnings and revenue estimates positively influences investor sentiment and stock trajectory.
PACS Group, Inc. reported first quarter 2026 financial results. Quarterly earnings releases directly shape financial performance perceptions and stock trajectory.
1 May
PACS Group, Inc. announces acquisition of a skilled nursing facility in Alaska alongside plans for new construction of a skilled nursing community. Acquisition in a new state and new facility construction represent major strategic expansion enhancing growth and market position.
PACS Group, Inc. (PACS) appoints Carey P. Hendrickson as its new Chief Financial Officer. CFO appointment influences financial strategy and investor sentiment without fundamentally altering core operations.
27 Apr
Wall Street analysts forecast PACS Group, Inc. (PACS) stock could surge 30.96%, urging investors to review details before betting. Analyst consensus targets 30.96% upside, signaling significant boost to investor sentiment and stock trajectory.
PACS Group, Inc. announces the appointment of Carey P. Hendrickson as Chief Financial Officer. Appointing a new CFO can influence financial strategy, reporting, and investor confidence.
PACS Group, Inc. announces the retirement of co-founder and CFO Mark Hancock. Retirement of co-founder and CFO introduces leadership transition risks that may moderately impact financial strategy and investor sentiment.
11 Mar
PACS Group, Inc. (PACS) upgraded to Strong Buy by analysts due to robust growth prospects, strong financial performance, and favorable industry tailwinds. Analyst upgrade to Strong Buy highlights major positive shift in investor sentiment and potential stock trajectory.
5 Mar
Wall Street analysts expect PACS Group, Inc. (PACS) stock to rally 25.45%, prompting evaluation of its realization potential. Analyst-projected 25.45% upside for PACS moderately influences investor sentiment and stock trajectory.
PACS Group, Inc. (PACS) named best momentum stock to buy for March 5th due to strong price performance and positive trends. Momentum stock recommendation expected to moderately influence investor sentiment and short-term trading activity.